La vendita allo scoperto per Marygold Companies dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Marygold Companies. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Marygold Companies (AMEX:MGLD) Azioni, Report sulle vendite allo scoperto

Marygold Companies

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

The Marygold Companies, Inc. Common Stock

The Marygold Companies Inc

Medgold Resources Corp

<p>Leafly Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFLY#NASDAQ">LFLY</a>) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.85) by 45.88 percent. This is a 58.18 percent increase over losses of $(1.10) per share from the same period last year.  The company reported quarterly sales of $8.35 million which missed the analyst consensus estimate of $8.38 million by 0.32 percent.  This is a 21.07 percent decrease over sales of $10.58 million the same period last year.</p>


Earnings

Earnings Beats

Earnings Misses

News

LFLY

Leafly Holdings Q3 EPS $(0.46) Beats $(0.85) Estimate, Sales $8.35M Miss $8.38M Estimate

<p>Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) reported quarterly earnings of $1.99 per share which met the analyst consensus estimate.  The company reported quarterly sales of $1.27 billion which missed the analyst consensus estimate of $1.33 billion by 4.16 percent.  This is a 22.78 percent increase over sales of $1.04 billion the same period last year.</p>


CIVI

Civitas Resources Q3 2024 Adj EPS $1.99, Inline, Sales $1.27B Miss $1.33B Estimate

Guidance

JAMF

Jamf Sees FY24 Revenue $626.3M-$627.3M Vs $624.072M Est; Sees Q4 Revenue $161.9M-$162.9M.

<p>Open Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) sees Q4 sales of $22.000 million-26.000 million vs $30.29 million estimate.</p>


LPRO

Open Lending Sees Q4 Sales $22.000M-26.000M vs $30.29M Est

<p>JFrog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.11 by 36.36 percent.  The company reported quarterly sales of $109.06 million which beat the analyst consensus estimate of $105.60 million by 3.27 percent.  This is a 23.04 percent increase over sales of $88.64 million the same period last year.</p>


FROG

JFrog Q3 2024 Adj EPS $0.15 Beats $0.11 Estimate, Sales $109.06M Beat $105.60M Estimate

XPOF

Xponential Fitness Reiterates FY24 Revenue $310M-$320M Vs $314.401M Est.

<p>Dynavax Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVAX#NASDAQ">DVAX</a>) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.11 by 9.09 percent.  The company reported quarterly sales of $80.630 million which missed the analyst consensus estimate of $84.166 million by 4.20 percent.  This is a 15.99 percent increase over sales of $69.514 million the same period last year.</p>


DVAX

Dynavax Technologies Q3 2024 GAAP EPS $0.12 Beats $0.11 Estimate, Sales $80.630M Miss $84.166M Estimate

QDEL

QuidelOrtho Sees FY24 Revenue $2.75B-$2.80B Vs $2.713B Est; Sees Adj EPS $1.69-$1.91 Vs $1.73 Est.

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HA Sustainable Infrastructure Capital Confirms Guidance For Adjusted EPS And Dividend Payout Ratio; Continues To Expect Annual Adjusted EPS To Grow At A Compounded Annual Rate Of 8%-10% From 2024-2026, Relative To The 2023 Baseline Of $2.23 Per Share, Which Is Equivalent To A 2026 Midpoint Of $2.89 Per Share; Expects Distributions Of Annual Dividends Per Share From 2024-2026 At A Payout Ratio Of Between 60%-70% Of Annual Adjusted EPS

<p>GoPro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) reported quarterly sales of $258.90 million which beat the analyst consensus estimate of $255.00 million by 1.53 percent.  This is a 12.03 percent decrease over sales of $294.30 million the same period last year.</p>


GPRO

GoPro Q3 Sales $258.90M Beat $255.00M Estimate

<p>Innodata (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) sees FY2024 sales of $163.137 million-166.608 million vs $137.46 million estimate.</p>


INOD

Innodata Sees FY2024 Sales to between 88% and 92% year-over-year.

<p>Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 23.53 percent.  The company reported quarterly sales of $65.15 million which beat the analyst consensus estimate of $62.60 million by 4.08 percent.  This is a 4.16 percent increase over sales of $62.55 million the same period last year.</p>


AAOI

Applied Optoelectronics Q3 2024 Adj EPS $(0.21) Misses $(0.17) Estimate, Sales $65.15M Beat $62.60M Estimate

<p>Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.16 by 37.5 percent.  The company reported quarterly sales of $159.300 million which beat the analyst consensus estimate of $157.566 million by 1.10 percent.  This is a 11.69 percent increase over sales of $142.625 million the same period last year.</p>


Jamf Holding Q3 2024 Adj. EPS $0.10 Misses $0.16 Estimate, Sales $159.300M Beat $157.566M Estimate

<p>Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent.  The company reported quarterly sales of $58.555 million which beat the analyst consensus estimate of $53.808 million by 8.82 percent.  This is a 12.39K percent increase over sales of $469.000 thousand the same period last year.</p>


IOVA

Iovance Biotherapeutics Q3 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $58.555M Beat $53.808M Estimate

<p>Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.17) by 17.65 percent. This is a 68.18 percent increase over losses of $(0.44) per share from the same period last year.  The company reported quarterly sales of $43.73 million which missed the analyst consensus estimate of $45.31 million by 3.50 percent.  This is a 1.58 percent increase over sales of $43.05 million the same period last year.</p>


CMBM

Cambium Networks Q3 Adj $(0.14) Beats $(0.17) Estimate, Sales $43.73M Miss $45.31M Estimate

<p>LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) sees Q4 sales of $57.000 million-58.000 million vs $57.34 million estimate.</p>


LFMD

LifeMD Sees Q4 Sales $57.000M-58.000M vs $57.34M Est

Savers Value Vllage Narrows FY24 Adj. Net Income From $82M-$96M To $81M-$86M

Contracts

Bloom Energy And Quanta Computer Announced A Major Expansion Of An Existing Agreement To Power The Production Of Critical Hardware  Serving The AI Industry; Terms Not Disclosed

<p>Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.37) by 16.22 percent.  The company reported quarterly sales of $446.52 million which beat the analyst consensus estimate of $430.37 million by 3.75 percent.  This is a 17.95 percent decrease over sales of $544.21 million the same period last year.</p>


Unity Software Q3 2024 GAAP EPS $(0.31) Beats $(0.37) Estimate, Sales $446.52M Beat $430.37M Estimate

<p>Mind Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent.</p>


MNMD

Mind Medicine Q3 2024 GAAP EPS $(0.27) Beats $(0.28) Estimate

Marygold Companies Inc (MGLD) is around the bottom of the Financial Services sector according to InvestorsObserver.MGLD received an overall rating of 0, which means that it scores higher than 0% of stocks. Additionally, Marygold Companies Inc scored a 0 in the Financial Services sector, ranking it higher than 0% of stocks

Is Marygold Companies Inc (MGLD) a Laggard in the Financial Services Sector?

Marygold Companies reports Q1 results

Coinbase, B. Riley Financial among financial movers

UP Fintech, Applied Digital among financial movers

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Marygold Companies</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/mgld-stock-quote/"><strong>MGLD</strong></a></span>) just reported results for the third quarter of 2024.</p><ul><li>Marygold Companies reported earnings per share of -1 cent.</li><li>The company reported revenue of $7.88 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/07/mgld-stock-earnings-marygold-companies-for-q3-of-2024/">MGLD Stock Earnings: Marygold Companies Reported Results for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

MGLD Stock Earnings: Marygold Companies Reported Results for Q3 2024

Marygold Companies GAAP EPS of -$0.05, revenue of $8.3M

The Marygold Companies secures private placement

Marygold Companies, Inc. ( ($MGLD) ) has provided an update. The Marygold Companies, Inc. has secured a $4.38 million funding through a private pla...

Marygold Companies Secures Funding for Fintech App Expansion

The Marygold Companies (MGLD) announced it has acquired a 7.95% ownership position, investing $1.8M in Delaware based Midland Capital Holdings Corp...

Comments

Marygold Companies

Vendite allo scoperto

Marygold Companies (AMEX:MGLD) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO